Complications and Discharge after Radical Cystectomy for Older Patients with Muscle-Invasive Bladder Cancer: The ELCAPA-27 Cohort Study.
complications
discharge
functional decline
geriatric assessment
length of hospital stay
older patient
radical cystectomy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
29 Nov 2021
29 Nov 2021
Historique:
received:
25
10
2021
revised:
16
11
2021
accepted:
25
11
2021
entrez:
10
12
2021
pubmed:
11
12
2021
medline:
11
12
2021
Statut:
epublish
Résumé
Radical cystectomy is the standard of care for localized bladder cancer but is associated with high morbidity and mortality rates-especially among older patients with comorbidities. The association between geriatric assessment parameters on post-operative complications and discharge has not previously been investigated. The present analysis of the Elderly Cancer Patient (ELCAPA) prospective cohort included all patients aged ≥70 having undergone a geriatric assessment and then radical cystectomy for localized muscle-invasive bladder cancer between 2007 and 2018. The primary endpoint was the proportion of patients with one or more complications in the first 30 days after cystectomy. The secondary endpoints were the length of hospital stay (LOS), the 30-day mortality, and discharge rates. Sixty-two patients (median age: 81; range: 79-83.8) were included. The 30-day complication rate was 73%, and 49% of the patients had experienced a major complication, according to the Clavien-Dindo classification. The 30-day mortality rate was 4%. None of the geriatric, oncological, or laboratory parameters were significantly associated with the occurrence or severity of complications. The median (interquartile range) LOS was 18 days (15-23) overall and was longer in patients with complications (19 days vs. 15 days in those without complications;
Identifiants
pubmed: 34885120
pii: cancers13236010
doi: 10.3390/cancers13236010
pmc: PMC8656698
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Br J Cancer. 2013 Apr 16;108(7):1534-40
pubmed: 23481180
J Urol. 2018 Feb;199(2):543-550
pubmed: 28789948
BMC Urol. 2018 Oct 22;18(1):91
pubmed: 30348141
Prog Urol. 2019 Feb;29(2):63-75
pubmed: 30635149
J Urol. 2017 Nov;198(5):1039-1045
pubmed: 28533006
J Urol. 2021 Jan;205(1):94-99
pubmed: 32716672
J Urol. 2012 Jun;187(6):2011-7
pubmed: 22498229
JAMA Netw Open. 2020 Aug 3;3(8):e209265
pubmed: 32822490
Ann Surg Oncol. 2014 Dec;21(13):4383-9
pubmed: 25047468
Clin Genitourin Cancer. 2017 Aug;15(4):e615-e621
pubmed: 28139446
Eur Urol. 2018 Jan;73(1):40-50
pubmed: 28478043
J Clin Oncol. 2011 Sep 20;29(27):3636-42
pubmed: 21709194
J Urol. 2006 Dec;176(6 Pt 1):2612-7; discussion 2617-8
pubmed: 17085172
Urology. 2011 Mar;77(3):660-6
pubmed: 21256568
Eur Urol. 2009 Jan;55(1):164-74
pubmed: 18675501
J Clin Oncol. 2018 Aug 1;36(22):2326-2347
pubmed: 29782209
Urology. 2018 Nov;121:39-43
pubmed: 30076943
J Geriatr Oncol. 2020 Sep;11(7):1043-1053
pubmed: 32057720
Can J Urol. 2013 Aug;20(4):6826-31
pubmed: 23930606
J Urol. 2021 Feb;205(2):400-406
pubmed: 32897772
Eur Urol. 2021 Jan;79(1):82-104
pubmed: 32360052
Int Urol Nephrol. 2008;40(4):893-9
pubmed: 18317944
Ther Adv Urol. 2020 May 10;12:1756287220916614
pubmed: 32435276